Gene-Therapy Trials for Inherited Form of Blindness Could Start in Two Years – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
Gene–Therapy Trials for Inherited Form of Blindness Could Start in Two Years
Genetic Engineering & Biotechnology News Scientists in the U.S. say human trials of gene therapy for an inherited form of blindness known as vitelliform macular degeneration, or Best disease, could be less than two years away, following successful use of the treatment in a canine model of the … Best Disease Blindness Bettered By Gene Therapy |
